Viatris is a pharmaceutical company. It develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. The company offers medicines for a range of therapeutic areas applications, including cardiovascular, oncology, women's healthcare, diabetes, respiratory, noncommunicable, and other diseases. Viatris was formed as a result of a merger between Mylan and Upjohn, a division of Pfizer.